Sanyou Biopharmaceuticals

Private

ShanghaiHealthcare & Life Scienceshttps://www.sanyoubio.com/

Last Round

Series B

Extension

Aug 2, 2022

Total Funding Raised

$5.78M

Momentum

Quiet

No recent growth signals

Company Overview

Sanyou Biopharmaceuticals is a biotechnology company that provides contract research, development, and manufacturing organization (CRDMO) services for innovative biologic and antibody drugs.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROantibody drug discoveryAI drug discoverycontract development organizationCDOantibody discovery platformbiologics discoveryAI biotechpreclinical developmentantibody engineeringcomputational drug discoverycell line developmentin vivo efficacy evaluationin vitro efficacy evaluationcollaborative project organizationCPO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sanyou Biopharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sanyou Biopharmaceuticals Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series B Extension	Aug 2, 2022
Series B	Jun 26, 2021
Series A	May 16, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

David Lang

Founder & CEO

Founding Team

Sanyou Biopharmaceuticals Investors

Notable investors and investment history

Investor	Rounds
Huatai Zijin Investment	Series B Extension
Grand Mount Capital	Series B
Linghang Ventures	Series B Extension, Series B
Huatai Zijin Investment	Series B Extension

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 20, 2026
Monthly visitors increased 164% MoM.
Jan 1, 2026
Monthly visitors increased 210% MoM, reaching 784.

View all signals

Sanyou Biopharmaceuticals Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sanyou Biopharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sanyou Biopharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range161

Year Founded2015

Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.